HDCN Online Slide/Audio Symposium    
American Society of Nephrology

Schein Pharmaceutical

Satellite Symposium of the American Society of Nephrology 32nd Annual Scientific Meeting, November, 1999
Schein Pharmaceutical, ASN Corporate Sponsor
Supported by an unrestricted educational grant from Schein Pharmaceutical, Inc.

Anemia Management:
The Changing Spectrum of Care
You need to REGISTER WITH HDCN (it's free) before you can access these talks. This program offers 1.5 hours of Category One CME Credit for Physicians and 1.8 contact hours for nurses through Medical Education Resources. For CME-related information click here
The Talks

Introductory Remarks
Steven Fishbane, M.D.

Components of Anemia Therapy
Steven Fishbane, M.D.

Optimal Anemia Management: Target Hematocrit
Allen R. Nissenson, M.D.

National Patterns of Iron Utilization: An Opportunity Recognized
William F. Owen, Jr. M.D.

New Advances in Iron Management
Allen R. Nissenson, M.D.

Questions and Answers
Drs. Fishbane, Nissenson, and Owen


Steven Fishbane, M.D., Associate Professor of Medicine and Associate Chairman, Department of Medicine, Winthrop-University Hospital, Mineola, NY

Allen R. Nissenson, M.D., Professor of Medicine, Director, Dialysis Program, University of California at Los Angeles, Los Angeles, CA

William F. Owen, Jr. M.D., Professor of Medicine, Director of Duke University Institute of Renal outcomes, Research and Health Policy, Duke University School of Medicine, Durham, NC

Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page